Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引：0
|
作者：
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构：
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-143
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [21] Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan
    H Sasaki
    A Manabe
    S Kojima
    M Tsuchida
    Y Hayashi
    K Ikuta
    J Okamura
    K Koike
    A Ohara
    E Ishii
    Y Komada
    S Hibi
    T Nakahata
    Leukemia, 2001, 15 : 1713 - 1720
  • [22] Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan
    Sasaki, H
    Manabe, A
    Kojima, S
    Tsuchida, M
    Hayashi, Y
    Ikuta, K
    Okamura, J
    Koike, K
    Ohara, A
    Ishii, E
    Komada, Y
    Hibi, S
    Nakahata, T
    LEUKEMIA, 2001, 15 (11) : 1713 - 1720
  • [23] Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline
    J. Vansteenkiste
    D. Tomita
    G. Rossi
    R. Pirker
    Supportive Care in Cancer, 2004, 12 : 253 - 262
  • [24] Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline
    Vansteenkiste, J
    Tomita, D
    Rossi, G
    Pirker, R
    SUPPORTIVE CARE IN CANCER, 2004, 12 (04) : 253 - 262
  • [25] Characteristics and Outcomes of Patients With Myelodysplastic Syndrome and DDX41 Mutation
    Bataller, Alex
    Loghavi, Sanam
    Gerstein, Yoheved
    Bazinet, Alexandre
    Sasaki, Koji
    Chien, Kelly S.
    Hammond, Danielle
    Montalban-Bravo, Guillermo
    Borthakur, Gautam
    Short, Nicholas
    Issa, Ghayas C.
    Kadia, Tapan M.
    Daver, Naval
    Patel, Keyur P.
    Ravandi, Farhad
    Fiskus, Warren
    Mill, Cristopher P.
    Kantarjian, Hagop M.
    Bhalla, Kapil
    Garcia-Manero, Guillermo
    Oran, Betul
    DiNardo, Courtney D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S357 - S358
  • [26] Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome A Retrospective Cohort Study
    Lee, Sang Jin
    Park, Jin Kyun
    Lee, Eun Young
    Joo, Sang Hyun
    Jung, Kyeong Cheon
    Lee, Eun Bong
    Song, Yeong Wook
    Yoon, Sung-Soo
    MEDICINE, 2016, 95 (13) : e3091
  • [27] The effectiveness of darbepoetin alfa administered every 3 weeks on hematologic outcomes and quality of life in older patients with chemotherapy-induced anemia
    Boccia, Ralph
    Lillie, Tom
    Tomita, Dianne
    Balducci, Lodovico
    ONCOLOGIST, 2007, 12 (05) : 584 - 593
  • [28] Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
    Mekinian, Arsene
    Dervin, Guillaume
    Lapidus, Nathanael
    Kahn, Jean-Emmanuel
    Terriou, Louis
    Liozon, Eric
    Grignano, Eric
    Piette, Jean-Charles
    Rauzy, Odile Beyne
    Grobost, Vincent
    Godmer, Pascal
    Gillard, Jerome
    Rossignol, Julien
    Launay, David
    Aouba, Achille
    Cardon, Thierry
    Bouillet, Laurence
    Broner, Jonathan
    Vinit, Julien
    Ades, Lionel
    Carrat, Fabrice
    Salvado, Clementine
    Toussirot, Eric
    Versini, Mathilde
    Costedoat-Chalumeau, Nathalie
    Fraison, Jean Baptiste
    Guilpain, Philippe
    Fenaux, Pierre
    Fain, Olivier
    AUTOIMMUNITY REVIEWS, 2017, 16 (09) : 903 - 910
  • [29] Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study
    Lee, Je-Hwan
    Kim, Yoo-Jin
    Sohn, Sang Kyun
    Yoon, Sung-Soo
    Kim, Hawk
    Cheong, June-Won
    Lee, Won-Sik
    Lee, Gyeong-Won
    Lim, Sung-Nam
    Kim, Min Kyoung
    Lee, Ho Sup
    Kim, Hyeoung-Joon
    LEUKEMIA RESEARCH, 2017, 60 : 135 - 144
  • [30] Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
    M. A. Aloe Spiriti
    R. Latagliata
    P. Niscola
    A. Cortelezzi
    M. Francesconi
    D. Ferrari
    E. Volpe
    M. Clavio
    A. Grossi
    M. Tambone Reyes
    P. Musto
    M. E. Mitra
    A. Azzarà
    D. Pagnini
    G. D’Arena
    A. Spadano
    E. Balleari
    P. Pecorari
    E. Capochiani
    E. De Biasi
    D. Perego
    B. Monarca
    F. Pisani
    G. Scaramella
    M. C. Petti
    Annals of Hematology, 2005, 84 : 167 - 176
12345